Richardson Jason Andrew 4
Research Summary
AI-generated summary
Inogen CFO Jason Richardson Receives 100,000 RSU Award
What Happened
Jason Andrew Richardson (EVP, Chief Financial Officer & Treasurer) was granted 100,000 restricted stock units (RSUs) on April 6, 2026. The Form 4 reports the award as a derivative grant (transaction code A) with a reported price of $0.00 — no shares were sold or bought on the open market in this filing. The RSUs represent a contingent right to receive common stock upon vesting.
Key Details
- Transaction date: April 6, 2026; Form 4 filed: April 8, 2026 (timely filing).
- Grant: 100,000 RSUs; reported price: $0.00 (derivative award).
- Each RSU equals a contingent right to one share of Inogen common stock (Footnote F1).
- Vesting: subject to continued service — 1/3 of the RSUs vest one year after the Vesting Commencement Date (June 1, 2026), and 1/3 vest on each annual anniversary thereafter (Footnote F2).
- Shares owned after the transaction: not disclosed in the provided filing excerpt.
- Transaction code: A = Award/Grant (compensation/retention), not an open‑market purchase or sale.
Context
RSUs are a form of compensation that convert into actual shares only upon vesting; no cash changed hands at grant and there is no immediate market signal from this award alone. The ultimate value Richardson realizes will depend on Inogen’s share price at each vesting date. This filing documents the grant and vesting terms but does not indicate any sale or purchase of existing shares.